Australia markets open in 4 hours 49 minutes

Beximco Pharmaceuticals Limited (BXP.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
37.50+1.00 (+2.74%)
At close: 01:19PM BST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in BDT. All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Cash flows from operating activities
Net income
5,330,373
4,614,066
5,123,137
5,127,694
3,514,687
Depreciation & amortisation
-
2,060,503
1,667,010
-
-
Change in working capital
-
-734,170
-1,909,440
-
-
Inventory
-
-1,828,926
-2,565,078
-
-
Other working capital
5,962,130
3,374,759
2,274,678
3,464,846
3,267,186
Net cash provided by operating activities
-
6,084,787
5,214,176
-
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,410,756
-2,710,028
-2,939,498
-2,558,418
-2,275,301
Acquisitions, net
-
0
-4,766,636
0
-
Sales/maturities of investments
-
-
-
-
323,365
Net cash used for investing activities
-2,582,989
-2,617,018
-7,680,054
-2,524,646
-1,946,862
Net change in cash
130,235
-92,802
149,347
40,450
22,554
Cash at beginning of period
983,806
1,168,674
973,964
635,017
610,494
Cash at end of period
1,114,041
1,135,686
1,168,674
675,467
635,017
Free cash flow
Operating cash flow
-
6,084,787
5,214,176
-
-
Capital expenditure
-2,410,756
-2,710,028
-2,939,498
-2,558,418
-2,275,301
Free cash flow
5,962,130
3,374,759
2,274,678
3,464,846
3,267,186